Does human papillomavirus play a role in the development of bladder transitional cell carcinoma? A comparison of PCR and immunohistochemical analysis

Journal of Clinical Pathology

Volumn 58, Issue 2, 2005, Pages 207-210

  Youshya, S ^b   Purdie, K ^b   Breuer, J ^b   Proby, C ^b   Sheaf, M T ^a   Oliver, R T D ^a   Baithun, S ^a  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

^b Centre for Cutaneous Research   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; OLIGONUCLEOTIDE; PARAFFIN; POLYCLONAL ANTIBODY; VIRUS ANTIGEN; VIRUS DNA;

ADULT; AGAR GEL ELECTROPHORESIS; AGED; ARTICLE; BLADDER CARCINOMA; CONTROLLED STUDY; ENZYME IMMUNOASSAY; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MUCOSA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; UTERINE CERVIX CARCINOMA; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; ANTIGENS, VIRAL; CAPSID PROTEINS; CARCINOMA, TRANSITIONAL CELL; DNA, VIRAL; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; URINARY BLADDER NEOPLASMS;

EID: 13244298509     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2004.017152     Document Type: Article

References (29)

1. Bosch FX, Lorincz A, Munoz N, et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002;55:244-65.
2. McGregor JM, Rustin MH. Human papillomavirus and skin cancer. Postgrad Med J 1994;70:682-5.
3. Jenson AB, Geyer S, Sundberg JP, et al. Human papillomavirus and skin cancer. J Investig Dermatol Symp Proc 2001;6:203-6.
4. Barzal-Nowosielska M, Miasko A, Staroslawska E, et al. Detection of human papillomavirus in papillomas of oral cavity. Folia Histochem Cytobiol 2001;39(suppl 2):189-90.
5. Giovannelli L, Campisi G, Lama A, et al. Human papillomavirus DNA in oral mucosal lesions. J Infect Dis 2002;185:833-6.
6. Syrjanen KJ. HPV infections and oesophageal cancer. J Clin Pathol 2002;55:721-8.
7. Sjo NC, Heegaard S, Prause JU, et al. Human papillomavirus in conjunctival papilloma. Br J Ophthalmol 2001;85:785-7.
8. zur Hausen H. Papillomavirus infections - a major cause of human cancers. Biochim Biophys Acta 1996;1288:F55-78.
9. Young R. Usual variants of primary bladder lesions and secondary tumours of the bladder. In: Pathology of bladder cancer. Baltimore: Williams and Wilkins, 1990:326-37.
10. Malone TJ, Folberg R, Nerad JA. Lumbosacral chordoma metastatic to the eyelid. Ophthalmology 1987;94:966-70.
11. Campo MS. Bovine papillomavirus and cancer. Vet J 1997;154:175-88.
12. a Jenkins BJ, Martin JE, Baithun SI, et al. Prediction of response to radiotherapy in invasive cancer. Br J Urol 1990;65:345-8.
13. Sur M, Cooper K, Allard U. Investigation of human papillomavirus in transitional cell carcinomas of the urinary bladder in South Africa. Pathology 2001;33:17-20.
14. Jacobs MV, Snijders PJ, van den Brule AJ, et al. A general primer GP5+/ GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J Clin Microbiol 1997;35:791-5.
15. de Roda Husman AM, Walboomers JM, van den Brule AJ, et al. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 1995;76:1057-62.
16. Hiyama K, Kodaira M, Satoh C. Detection of deletions, insertions and single nucleotide substitutions in cloned beta-globin genes and new polymorphic nucleotide substitutions in beta-globin genes in a Japanese population using ribonuclease cleavage at mismatches in RNA:DNA duplexes. Mutat Res 1990;231:219-31.
17. Hall TA. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp Ser 1999;41:95-8.
18. Jacobs MV, de Roda Husman AM, von den Brule AJ, et al. Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes. J Clin Microbiol 1995;33:901-5.
19. Jacobs MV, van den Brule AJ, Snijders PJ, et al. A non-radioactive PCR enzyme-immunoassay enables a rapid identification of HPV 16 and 18 in cervical scrapes after GP5+/6+ PCR. J Med Virol 1996;49:223-9.
20. Lopez-Beltran A, Escudero AL, Carrasco-Aznar JC, et al. Human papillomavirus infection and transitional cell carcinoma of the bladder. Immunohistochemistry and in situ hybridization. Pathol Res Pract 1996;192:154-9.
21. Lopez-Beltran A, Escudero AL, Vicioso L, et al. Human papillomavirus DNA as a factor determining the survival of bladder cancer patients. Br J Cancer 1996;73:124-7.
22. Aynaud O, Piron D, Barrasso R, et al. Comparison of clinical, histological, and virological symptoms of HPV in HIV-1 infected men and immunocompetent subjects. Sex Transm Infect 1998;74:32-4.
23. Chetsanga C, Malmstrom PU, Gyllensten U, et al. Low incidence of human papillomavirus type 16 DNA in bladder tumor detected by the polymerase chain reaction. Cancer 1992;69:1208-11.
24. De Gaetani C, Ferrari G, Righi E, et al. Detection of human papillomavirus DNA in urinary bladder carcinoma by in situ hybridisation. J Clin Pathol 1999;52:103-6.
25. Chan KW, Wong KY, Srivastava G. Prevalence of six types of human papillomavirus in inverted papilloma and papillary transitional cell carcinoma of the bladder: an evaluation by polymerase chain reaction. J Clin Pathol 1997;50:1018-21.
26. Anwar K, Nakakuki K, Shiraishi T, et al. Presence of ras oncogene mutations and human papillomavirus DNA in human prostate carcinomas. Cancer Res 1992;52:5991-6.
27. Furihata M, Ohtsuki Y, Ogoshi S, et al. Prognostic significance of human papillomavirus genomes (type-16, -18) and aberrant expression of p53 protein in human esophageal cancer. Int J Cancer 1993;54:226-30.
28. Yu Z, Xia T, Xue Z. (The detection of high risk human papillomaviruses in papillary transitional cell carcinoma of urinary bladder.) Zhonghua Wai Ke Za Zhi 1999;37:369-71.
29. Simoneau M, LaRue H, Fradet Y. Low frequency of human papillomavirus infection in initial papillary bladder tumors. Urol Res 1999;27:180-4.